Artificial Cardiac Pacemaker Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
A cardiac pacemaker is a medical device that generates electrical impulses delivered by electrodes to cause the heart muscle chambers to contract and pump blood. This device replaces and/or regulates the function of the heart's electrical conduction system. It is also known as an artificial pacemaker to distinguish it from its natural counterpart. The primary function of a pacemaker is to keep the heart rate stable. Modern devices are demand pacemakers, which stimulate the heart based on the circulatory system's dynamic demand. They are externally programmable, allowing a cardiologist to choose the best pacing modes for individual patients.
MARKET SCOPE
The artificial cardiac pacemaker market is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the artificial cardiac pacemaker market with detailed market segmentation by product, type, end-user, and geography. The report provides key statistics on the market status of the leading artificial cardiac pacemaker market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- On the basis of Product, the Artificial Cardiac Pacemaker Market is segmented into Single Chamber Cardiac Pacemaker, Dual Chamber Cardiac Pacemakers, and Cardiac Re-synchronization Therapy Pacemaker (CRT-P).
- By End-user, the market is segmented into Hospitals, Ambulatory Surgery Centers, and Others.
- On the basis of implantability, the market is segmented into Implantable Pacemaker and External Pacemaker.
- On the basis of type, the Artificial Cardiac Pacemaker Market is segmented into MRI Compatible Pacemaker and Conventional Pacemaker.
MARKET DYNAMICS
Drivers:
- Increasing incidence of Cardiovascular Diseases (CVDs).
- Technological advancement in pacemakers.
- Availability of reimbursement for pacemaker implantation procedures.
- Lead displacement is one of the common occurrences with pacemakers.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South And Central America. The Artificial Cardiac Pacemaker Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Artificial Cardiac Pacemaker Market in these regions.
IMPACT OF COVID-19 ON ARTIFICIAL CARDIAC PACEMAKER MARKET
COVID-19 first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected the growth of this market worldwide due to the business shutdown, worldwide lockdown, and supply and trade disruptions. While the situation is rapidly evolving, the pandemic had already disrupted the world in three ways the direct health impact the impact on the healthcare system, and the social and economic consequences of the pandemic. It led to a significant decrease in elective cardiovascular (CV) procedures, especially in patients with associated chronic diseases such as diabetes mellitus. The emergence of the pandemic urged the Centers for Medicare and Medicaid Services (CMS) in March 2021 to postpone all elective surgeries, non-essential medical procedures, and dental procedures. This included all types of invasive and non-invasive cardiovascular exams and procedures, affecting all facets of cardiology departments, from ECG and echo labs to interventional and EP labs and cardiovascular surgeries.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South And Central America. The Artificial Cardiac Pacemaker Market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South And Central America after evaluating political, economic, social and technological factors affecting the Artificial Cardiac Pacemaker Market in these regions.
IMPACT OF COVID-19 ON ARTIFICIAL CARDIAC PACEMAKER MARKET
COVID-19 first began in Wuhan (China) in December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. The pandemic has affected the growth of this market worldwide due to the business shutdown, worldwide lockdown, and supply and trade disruptions. While the situation is rapidly evolving, the pandemic had already disrupted the world in three ways the direct health impact the impact on the healthcare system, and the social and economic consequences of the pandemic. It led to a significant decrease in elective cardiovascular (CV) procedures, especially in patients with associated chronic diseases such as diabetes mellitus. The emergence of the pandemic urged the Centers for Medicare and Medicaid Services (CMS) in March 2021 to postpone all elective surgeries, non-essential medical procedures, and dental procedures. This included all types of invasive and non-invasive cardiovascular exams and procedures, affecting all facets of cardiology departments, from ECG and echo labs to interventional and EP labs and cardiovascular surgeries.
MARKET PLAYERS
The report covers key developments in the artificial cardiac pacemaker market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, partnerships & collaborations. These activities have paved the way for the expansion of the business and customer base of market players. The market players in the artificial cardiac pacemaker market are anticipated to have lucrative growth opportunities in the future with the rising demand for artificial cardiac pacemaker market in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Artificial Cardiac Pacemaker Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, and the key development in the past five years.
- Medtronic
- Boston Scientific
- Biotronik
- LivaNova
- Medico
- IMZ
- Pacetronix
- Lepu
- Abbott
- Vitatron
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Artificial Cardiac Pacemaker Market - By Product
1.3.2 Artificial Cardiac Pacemaker Market - By End-user
1.3.3 Artificial Cardiac Pacemaker Market - By Implantability
1.3.4 Artificial Cardiac Pacemaker Market - By Type
1.3.5 Artificial Cardiac Pacemaker Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ARTIFICIAL CARDIAC PACEMAKER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ARTIFICIAL CARDIAC PACEMAKER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ARTIFICIAL CARDIAC PACEMAKER MARKET - GLOBAL MARKET ANALYSIS
6.1. ARTIFICIAL CARDIAC PACEMAKER - GLOBAL MARKET OVERVIEW
6.2. ARTIFICIAL CARDIAC PACEMAKER - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ARTIFICIAL CARDIAC PACEMAKER MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. SINGLE CHAMBER CARDIAC PACEMAKER
7.3.1. Overview
7.3.2. Single Chamber Cardiac Pacemaker Market Forecast and Analysis
7.4. DUAL CHAMBER CARDIAC PACEMAKER
7.4.1. Overview
7.4.2. Dual Chamber Cardiac Pacemaker Market Forecast and Analysis
7.5. CARDIAC RE-SYNCHRONIZATION THERAPY PACEMAKE.R
7.5.1. Overview
7.5.2. Cardiac Re-synchronization Therapy Pacemake.r Market Forecast and Analysis
8. ARTIFICIAL CARDIAC PACEMAKER MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. AMBULATORY SURGERY CENTERS
8.4.1. Overview
8.4.2. Ambulatory Surgery Centers Market Forecast and Analysis
8.5. AND OTHERS.
8.5.1. Overview
8.5.2. and Others. Market Forecast and Analysis
9. ARTIFICIAL CARDIAC PACEMAKER MARKET - REVENUE AND FORECASTS TO 2028 - IMPLANTABILITY
9.1. OVERVIEW
9.2. IMPLANTABILITY MARKET FORECASTS AND ANALYSIS
9.3. IMPLANTABLE PACEMAKER
9.3.1. Overview
9.3.2. Implantable Pacemaker Market Forecast and Analysis
9.4. EXTERNAL PACEMAKER.
9.4.1. Overview
9.4.2. External Pacemaker. Market Forecast and Analysis
10. ARTIFICIAL CARDIAC PACEMAKER MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
10.1. OVERVIEW
10.2. TYPE MARKET FORECASTS AND ANALYSIS
10.3. MRI COMPATIBLE PACEMAKER AND CONVENTIONAL PACEMAKER
10.3.1. Overview
10.3.2. MRI Compatible Pacemaker and Conventional Pacemaker Market Forecast and Analysis
11. ARTIFICIAL CARDIAC PACEMAKER MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Artificial Cardiac Pacemaker Market Overview
11.1.2 North America Artificial Cardiac Pacemaker Market Forecasts and Analysis
11.1.3 North America Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Product
11.1.4 North America Artificial Cardiac Pacemaker Market Forecasts and Analysis - By End-user
11.1.5 North America Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Implantability
11.1.6 North America Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Type
11.1.7 North America Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Countries
11.1.7.1 United States Artificial Cardiac Pacemaker Market
11.1.7.1.1 United States Artificial Cardiac Pacemaker Market by Product
11.1.7.1.2 United States Artificial Cardiac Pacemaker Market by End-user
11.1.7.1.3 United States Artificial Cardiac Pacemaker Market by Implantability
11.1.7.1.4 United States Artificial Cardiac Pacemaker Market by Type
11.1.7.2 Canada Artificial Cardiac Pacemaker Market
11.1.7.2.1 Canada Artificial Cardiac Pacemaker Market by Product
11.1.7.2.2 Canada Artificial Cardiac Pacemaker Market by End-user
11.1.7.2.3 Canada Artificial Cardiac Pacemaker Market by Implantability
11.1.7.2.4 Canada Artificial Cardiac Pacemaker Market by Type
11.1.7.3 Mexico Artificial Cardiac Pacemaker Market
11.1.7.3.1 Mexico Artificial Cardiac Pacemaker Market by Product
11.1.7.3.2 Mexico Artificial Cardiac Pacemaker Market by End-user
11.1.7.3.3 Mexico Artificial Cardiac Pacemaker Market by Implantability
11.1.7.3.4 Mexico Artificial Cardiac Pacemaker Market by Type
11.2. EUROPE
11.2.1 Europe Artificial Cardiac Pacemaker Market Overview
11.2.2 Europe Artificial Cardiac Pacemaker Market Forecasts and Analysis
11.2.3 Europe Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Product
11.2.4 Europe Artificial Cardiac Pacemaker Market Forecasts and Analysis - By End-user
11.2.5 Europe Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Implantability
11.2.6 Europe Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Type
11.2.7 Europe Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Artificial Cardiac Pacemaker Market
11.2.7.1.1 Germany Artificial Cardiac Pacemaker Market by Product
11.2.7.1.2 Germany Artificial Cardiac Pacemaker Market by End-user
11.2.7.1.3 Germany Artificial Cardiac Pacemaker Market by Implantability
11.2.7.1.4 Germany Artificial Cardiac Pacemaker Market by Type
11.2.7.2 France Artificial Cardiac Pacemaker Market
11.2.7.2.1 France Artificial Cardiac Pacemaker Market by Product
11.2.7.2.2 France Artificial Cardiac Pacemaker Market by End-user
11.2.7.2.3 France Artificial Cardiac Pacemaker Market by Implantability
11.2.7.2.4 France Artificial Cardiac Pacemaker Market by Type
11.2.7.3 Italy Artificial Cardiac Pacemaker Market
11.2.7.3.1 Italy Artificial Cardiac Pacemaker Market by Product
11.2.7.3.2 Italy Artificial Cardiac Pacemaker Market by End-user
11.2.7.3.3 Italy Artificial Cardiac Pacemaker Market by Implantability
11.2.7.3.4 Italy Artificial Cardiac Pacemaker Market by Type
11.2.7.4 United Kingdom Artificial Cardiac Pacemaker Market
11.2.7.4.1 United Kingdom Artificial Cardiac Pacemaker Market by Product
11.2.7.4.2 United Kingdom Artificial Cardiac Pacemaker Market by End-user
11.2.7.4.3 United Kingdom Artificial Cardiac Pacemaker Market by Implantability
11.2.7.4.4 United Kingdom Artificial Cardiac Pacemaker Market by Type
11.2.7.5 Russia Artificial Cardiac Pacemaker Market
11.2.7.5.1 Russia Artificial Cardiac Pacemaker Market by Product
11.2.7.5.2 Russia Artificial Cardiac Pacemaker Market by End-user
11.2.7.5.3 Russia Artificial Cardiac Pacemaker Market by Implantability
11.2.7.5.4 Russia Artificial Cardiac Pacemaker Market by Type
11.2.7.6 Rest of Europe Artificial Cardiac Pacemaker Market
11.2.7.6.1 Rest of Europe Artificial Cardiac Pacemaker Market by Product
11.2.7.6.2 Rest of Europe Artificial Cardiac Pacemaker Market by End-user
11.2.7.6.3 Rest of Europe Artificial Cardiac Pacemaker Market by Implantability
11.2.7.6.4 Rest of Europe Artificial Cardiac Pacemaker Market by Type
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Artificial Cardiac Pacemaker Market Overview
11.3.2 Asia-Pacific Artificial Cardiac Pacemaker Market Forecasts and Analysis
11.3.3 Asia-Pacific Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Product
11.3.4 Asia-Pacific Artificial Cardiac Pacemaker Market Forecasts and Analysis - By End-user
11.3.5 Asia-Pacific Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Implantability
11.3.6 Asia-Pacific Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Type
11.3.7 Asia-Pacific Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Artificial Cardiac Pacemaker Market
11.3.7.1.1 Australia Artificial Cardiac Pacemaker Market by Product
11.3.7.1.2 Australia Artificial Cardiac Pacemaker Market by End-user
11.3.7.1.3 Australia Artificial Cardiac Pacemaker Market by Implantability
11.3.7.1.4 Australia Artificial Cardiac Pacemaker Market by Type
11.3.7.2 China Artificial Cardiac Pacemaker Market
11.3.7.2.1 China Artificial Cardiac Pacemaker Market by Product
11.3.7.2.2 China Artificial Cardiac Pacemaker Market by End-user
11.3.7.2.3 China Artificial Cardiac Pacemaker Market by Implantability
11.3.7.2.4 China Artificial Cardiac Pacemaker Market by Type
11.3.7.3 India Artificial Cardiac Pacemaker Market
11.3.7.3.1 India Artificial Cardiac Pacemaker Market by Product
11.3.7.3.2 India Artificial Cardiac Pacemaker Market by End-user
11.3.7.3.3 India Artificial Cardiac Pacemaker Market by Implantability
11.3.7.3.4 India Artificial Cardiac Pacemaker Market by Type
11.3.7.4 Japan Artificial Cardiac Pacemaker Market
11.3.7.4.1 Japan Artificial Cardiac Pacemaker Market by Product
11.3.7.4.2 Japan Artificial Cardiac Pacemaker Market by End-user
11.3.7.4.3 Japan Artificial Cardiac Pacemaker Market by Implantability
11.3.7.4.4 Japan Artificial Cardiac Pacemaker Market by Type
11.3.7.5 South Korea Artificial Cardiac Pacemaker Market
11.3.7.5.1 South Korea Artificial Cardiac Pacemaker Market by Product
11.3.7.5.2 South Korea Artificial Cardiac Pacemaker Market by End-user
11.3.7.5.3 South Korea Artificial Cardiac Pacemaker Market by Implantability
11.3.7.5.4 South Korea Artificial Cardiac Pacemaker Market by Type
11.3.7.6 Rest of Asia-Pacific Artificial Cardiac Pacemaker Market
11.3.7.6.1 Rest of Asia-Pacific Artificial Cardiac Pacemaker Market by Product
11.3.7.6.2 Rest of Asia-Pacific Artificial Cardiac Pacemaker Market by End-user
11.3.7.6.3 Rest of Asia-Pacific Artificial Cardiac Pacemaker Market by Implantability
11.3.7.6.4 Rest of Asia-Pacific Artificial Cardiac Pacemaker Market by Type
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Artificial Cardiac Pacemaker Market Overview
11.4.2 Middle East and Africa Artificial Cardiac Pacemaker Market Forecasts and Analysis
11.4.3 Middle East and Africa Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Product
11.4.4 Middle East and Africa Artificial Cardiac Pacemaker Market Forecasts and Analysis - By End-user
11.4.5 Middle East and Africa Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Implantability
11.4.6 Middle East and Africa Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Type
11.4.7 Middle East and Africa Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Artificial Cardiac Pacemaker Market
11.4.7.1.1 South Africa Artificial Cardiac Pacemaker Market by Product
11.4.7.1.2 South Africa Artificial Cardiac Pacemaker Market by End-user
11.4.7.1.3 South Africa Artificial Cardiac Pacemaker Market by Implantability
11.4.7.1.4 South Africa Artificial Cardiac Pacemaker Market by Type
11.4.7.2 Saudi Arabia Artificial Cardiac Pacemaker Market
11.4.7.2.1 Saudi Arabia Artificial Cardiac Pacemaker Market by Product
11.4.7.2.2 Saudi Arabia Artificial Cardiac Pacemaker Market by End-user
11.4.7.2.3 Saudi Arabia Artificial Cardiac Pacemaker Market by Implantability
11.4.7.2.4 Saudi Arabia Artificial Cardiac Pacemaker Market by Type
11.4.7.3 U.A.E Artificial Cardiac Pacemaker Market
11.4.7.3.1 U.A.E Artificial Cardiac Pacemaker Market by Product
11.4.7.3.2 U.A.E Artificial Cardiac Pacemaker Market by End-user
11.4.7.3.3 U.A.E Artificial Cardiac Pacemaker Market by Implantability
11.4.7.3.4 U.A.E Artificial Cardiac Pacemaker Market by Type
11.4.7.4 Rest of Middle East and Africa Artificial Cardiac Pacemaker Market
11.4.7.4.1 Rest of Middle East and Africa Artificial Cardiac Pacemaker Market by Product
11.4.7.4.2 Rest of Middle East and Africa Artificial Cardiac Pacemaker Market by End-user
11.4.7.4.3 Rest of Middle East and Africa Artificial Cardiac Pacemaker Market by Implantability
11.4.7.4.4 Rest of Middle East and Africa Artificial Cardiac Pacemaker Market by Type
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Artificial Cardiac Pacemaker Market Overview
11.5.2 South and Central America Artificial Cardiac Pacemaker Market Forecasts and Analysis
11.5.3 South and Central America Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Product
11.5.4 South and Central America Artificial Cardiac Pacemaker Market Forecasts and Analysis - By End-user
11.5.5 South and Central America Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Implantability
11.5.6 South and Central America Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Type
11.5.7 South and Central America Artificial Cardiac Pacemaker Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Artificial Cardiac Pacemaker Market
11.5.7.1.1 Brazil Artificial Cardiac Pacemaker Market by Product
11.5.7.1.2 Brazil Artificial Cardiac Pacemaker Market by End-user
11.5.7.1.3 Brazil Artificial Cardiac Pacemaker Market by Implantability
11.5.7.1.4 Brazil Artificial Cardiac Pacemaker Market by Type
11.5.7.2 Argentina Artificial Cardiac Pacemaker Market
11.5.7.2.1 Argentina Artificial Cardiac Pacemaker Market by Product
11.5.7.2.2 Argentina Artificial Cardiac Pacemaker Market by End-user
11.5.7.2.3 Argentina Artificial Cardiac Pacemaker Market by Implantability
11.5.7.2.4 Argentina Artificial Cardiac Pacemaker Market by Type
11.5.7.3 Rest of South and Central America Artificial Cardiac Pacemaker Market
11.5.7.3.1 Rest of South and Central America Artificial Cardiac Pacemaker Market by Product
11.5.7.3.2 Rest of South and Central America Artificial Cardiac Pacemaker Market by End-user
11.5.7.3.3 Rest of South and Central America Artificial Cardiac Pacemaker Market by Implantability
11.5.7.3.4 Rest of South and Central America Artificial Cardiac Pacemaker Market by Type
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ARTIFICIAL CARDIAC PACEMAKER MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Middle East and Africa
12.5 South and Central America
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. ARTIFICIAL CARDIAC PACEMAKER MARKET, KEY COMPANY PROFILES
14.1. MEDTRONIC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. BOSTON SCIENTIFIC
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BIOTRONIK
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. LIVANOVA
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. MEDICO
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. IMZ
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. PACETRONIX
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. LEPU
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ABBOTT
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. VITATRON
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Medtronic
2. Boston Scientific
3. Biotronik
4. LivaNova
5. Medico
6. IMZ
7. Pacetronix
8. Lepu
9. Abbott
10. Vitatron
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For